PriceTargets.com logo

Enovix - ENVX Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $20.50
  • Forecasted Upside: 110.69%
  • Number of Analysts: 11
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 8 Buy Ratings
  • 1 Strong Buy Ratings
$9.73 As of 12/20/2024 06:45 PM ET
▲ +1.7 (21.17%)

This chart shows the closing price for ENVX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Enovix Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ENVX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ENVX

Analyst Price Target is $20.50
▲ +110.69% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for Enovix in the last 3 months. The average price target is $20.50, with a high forecast of $36.00 and a low forecast of $10.00. The average price target represents a 110.69% upside from the last price of $9.73.

This chart shows the closing price for ENVX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 11 investment analysts is to moderate buy stock in Enovix. This rating has held steady since October 2024, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/30/2023
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/28/2023
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/27/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/24/2024
  • 1 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/22/2024
  • 1 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
11/21/2024
  • 1 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
12/21/2024

Latest Recommendations

  • 1 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/31/2024Janney Montgomery ScottDowngradeBuy ➝ Neutral$10.00
10/30/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$30.00 ➝ $30.00
10/30/2024BenchmarkReiterated RatingBuy ➝ Buy$25.00 ➝ $25.00
10/22/2024JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$18.00 ➝ $15.00
8/26/2024OppenheimerReiterated RatingOutperform ➝ Outperform$36.00 ➝ $36.00
8/5/2024Piper SandlerReiterated RatingOverweight ➝ Overweight$23.00 ➝ $19.00
8/1/2024TD CowenBoost TargetHold ➝ Hold$11.00 ➝ $14.00
8/1/2024Craig HallumBoost TargetBuy ➝ Buy$15.00 ➝ $20.00
8/1/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$30.00 ➝ $30.00
8/1/2024Canaccord Genuity GroupBoost TargetBuy ➝ Buy$17.00 ➝ $20.00
7/22/2024BenchmarkInitiated CoverageBuy$25.00
6/27/2024Canaccord Genuity GroupReiterated RatingBuy ➝ Buy$17.00 ➝ $17.00
6/25/2024B. RileyUpgradeStrong-Buy
5/2/2024Craig HallumLower TargetBuy ➝ Buy$20.00 ➝ $15.00
5/2/2024William BlairReiterated RatingOutperform
4/30/2024B. RileyLower TargetBuy ➝ Buy$18.00 ➝ $16.00
4/26/2024JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$18.00 ➝ $12.00
4/25/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$30.00
2/21/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$30.00
2/21/2024Canaccord Genuity GroupReiterated RatingBuy ➝ Buy$17.00
1/18/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$30.00
12/18/2023William BlairInitiated CoverageOutperform
11/8/2023B. RileyLower TargetBuy ➝ Buy$25.00 ➝ $18.00
11/8/2023Cantor FitzgeraldBoost TargetOverweight ➝ Overweight$28.00 ➝ $30.00
9/8/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$28.00
7/27/2023Craig HallumBoost TargetBuy$15.00 ➝ $28.00
7/21/2023TD CowenDowngradeOutperform ➝ Market Perform$19.00 ➝ $20.00
7/20/2023B. RileyBoost TargetBuy$18.00 ➝ $25.00
5/5/2023Robert W. BairdBoost Target$64.00 ➝ $67.00
4/20/2023JPMorgan Chase & Co.Boost Target$16.00 ➝ $18.00
3/29/2023EF Hutton Acquisition Co. IReiterated RatingBuy$18.00
3/10/2023Cantor FitzgeraldReiterated RatingOverweight$25.00
2/23/2023Craig HallumLower TargetBuy$23.00 ➝ $15.00
2/23/2023Piper SandlerBoost TargetOverweight$22.50 ➝ $25.00
2/23/2023EF Hutton Acquisition Co. IReiterated RatingBuy$18.00
1/27/2023EF Hutton Acquisition Co. ILower TargetBuy$23.00 ➝ $18.00
1/26/2023JPMorgan Chase & Co.Lower TargetOverweight$28.00 ➝ $16.00
1/23/2023Piper SandlerLower TargetOverweight$26.50 ➝ $22.50
1/11/2023Canaccord Genuity GroupInitiated CoverageBuy$20.00
1/4/2023B. RileyLower Target$19.00 ➝ $18.00
12/1/2022B. RileyInitiated CoverageBuy$19.00
11/4/2022Janney Montgomery ScottInitiated CoverageBuy$23.00
11/2/2022CowenLower Target$36.00 ➝ $25.00
11/2/2022CowenLower Target$36.00 ➝ $25.00
10/28/2022EF Hutton Acquisition Co. IInitiated CoverageBuy$25.00
9/28/2022Cantor FitzgeraldInitiated CoverageOverweight$25.00
9/20/2022Piper SandlerReiterated RatingOverweight$29.00
8/24/2022CowenBoost TargetOutperform$19.00 ➝ $36.00
8/24/2022CowenBoost Target$19.00 ➝ $36.00
8/22/2022Loop CapitalBoost TargetBuy$50.00 ➝ $100.00
8/11/2022Northland SecuritiesBoost TargetOutperform$22.00 ➝ $25.00
8/11/2022Craig HallumBoost TargetBuy$20.00 ➝ $25.00
8/9/2022Loop CapitalInitiated CoverageBuy$50.00
8/5/2022JPMorgan Chase & Co.Initiated CoverageOverweight$20.00
6/24/2022CowenLower TargetOutperform$24.00 ➝ $20.00
6/24/2022CowenLower TargetOutperform$24.00 ➝ $20.00
3/4/2022Craig HallumLower TargetBuy$50.00 ➝ $35.00
1/11/2022Piper SandlerLower Target$39.00 ➝ $35.00
1/4/2022CowenInitiated CoverageOutperform$32.00
12/17/2021Piper SandlerInitiated CoverageOverweight$39.00
12/2/2021Craig HallumInitiated CoverageBuy$50.00
11/9/2021OppenheimerBoost TargetOutperform$32.00 ➝ $38.00
8/16/2021OppenheimerInitiated CoverageOutperform$32.00
7/16/2021Northland SecuritiesInitiated CoverageBuy$25.00
(Data available from 12/21/2019 forward)

News Sentiment Rating

0.72 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 14 very positive mentions
  • 30 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
5/25/2024
  • 16 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/24/2024
  • 20 very positive mentions
  • 27 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/24/2024
  • 8 very positive mentions
  • 37 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/23/2024
  • 7 very positive mentions
  • 19 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 13 very positive mentions
  • 22 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2024
  • 13 very positive mentions
  • 29 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
Mentions as of
11/21/2024
  • 14 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2024

Current Sentiment

  • 14 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Enovix logo
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Read More

Today's Range

Now: $9.73
Low: $8.35
High: $10.07

50 Day Range

MA: $9.68
Low: $8.03
High: $12.81

52 Week Range

Now: $9.73
Low: $5.70
High: $18.68

Volume

15,718,198 shs

Average Volume

5,631,753 shs

Market Capitalization

$1.73 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.94

Frequently Asked Questions

What sell-side analysts currently cover shares of Enovix?

The following Wall Street analysts have issued reports on Enovix in the last year: B. Riley, Benchmark Co., Canaccord Genuity Group Inc., Cantor Fitzgerald, Craig Hallum, Janney Montgomery Scott, JPMorgan Chase & Co., Oppenheimer Holdings Inc., Piper Sandler, TD Cowen, and William Blair.
View the latest analyst ratings for ENVX.

What is the current price target for Enovix?

0 Wall Street analysts have set twelve-month price targets for Enovix in the last year. Their average twelve-month price target is $20.50, suggesting a possible upside of 110.7%. Oppenheimer Holdings Inc. has the highest price target set, predicting ENVX will reach $36.00 in the next twelve months. Janney Montgomery Scott has the lowest price target set, forecasting a price of $10.00 for Enovix in the next year.
View the latest price targets for ENVX.

What is the current consensus analyst rating for Enovix?

Enovix currently has 2 hold ratings, 8 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for ENVX.

What other companies compete with Enovix?

Other companies that are similar to Enovix include EnerSys, Fluence Energy, Atkore, Energizer and QuantumScape. Learn More about companies similar to Enovix.

How do I contact Enovix's investor relations team?

Enovix's physical mailing address is 575 EASTVIEW WAY, WOODSIDE CA, 94062. The company's listed phone number is 510-695-2350 and its investor relations email address is [email protected]. The official website for Enovix is www.rodgerscap.com. Learn More about contacing Enovix investor relations.